Unreported Truths in 2023 - (another) big year. Now, what's next?

With your help, I sued the President (and Pfizer's chairman). Berenson v Biden is steaming ahead. And though the fight over mRNA jabs isn't over, I have even bigger issues to tackle.

As 2023 began, the big question I faced for Unreported Truths was: what next?

As a public health threat, Covid - always overblown - had faded. Barring an unlikely mutation, it would only get milder.

Public opinion had swung against every Covid control measure, from lockdowns and school closures to mRNA “vaccines.”

—

(What next? More truth, that’s what.)

—

Meanwhile, the jabs themselves had failed to provide lasting protection -. Their side effects were worse than the vaccine companies had admitted. Their cardiac side effects could be deadly, particularly for young men.

But might they actually be dangerous to large numbers of people long-term? The answer was unclear. Research showed multiple mRNA doses changed unexpected changes to the immune system. And fall 2022 death data (particularly from Europe) suggested a second mRNA booster might drive up deaths in the elderly.

I hoped that clearer answers might be forthcoming in 2023.

They mostly weren’t. The truth is only the mRNA companies or governments have the data that would provide hard answers. If the jabs are dangerous long-term, the risks probably rise with each mRNA dose. But as fewer people get jabbed, the real-world epidemiology gets messy. Trying to tease out complex, long-term effects requires national-level datasets.

I don’t have those, and I’ll never get them. I expect to keep finding research that may have gone unnoticed - like a study from Pfizer itself showing the possible risks of giving flu and Covid jabs simultaneously, even as Pfizer ran its “Two Things At Once” ad. Ironically, some information may come from clinical trials the jab companies are now running for their non-Covid mRNA shots, and I will keep watching to those too.

But barring disaster, we may never get clear answers about the long-term health impact of the mRNAs. Reality is frustrating sometimes.

So what comes next? I have some ideas - and it seems you do too.

Spoiler alert: they’re about more than Covid and the mRNAs.

(To find out what they are about, subscribe. Or wait a week.)

A trend emerged this fall: non-Covid articles have often had higher readership and engagement than Covid-related stuff.

Most recently, this piece about Matthew Perry’s overdose death from ketamine generated significant attention. (Robert F. Kennedy Jr.’s Children’s Health Defense actually asked me if they could republish it.)

—

And when I have asked your thoughts about what to do next - moving to Rumble, for example, or writing a book about the vaccines - a lot of you have suggested either that you are happy to follow whatever reporting tracks I’m chasing or that I look more broadly at the crisis in American medicine.

That latter suggestion makes a lot of sense to me.

Because the mRNAs - expensive, rushed, heavily promoted, with side effects far worse than older and cheaper jabs, and with unknown long-term risks - are only the latest example of how the pharma-healthcare complex pushes its dubious technological innovations on patients worldwide.

For generations, the patent structure the United States has used for medicines has practically guaranteed that pharmaceutical companies would have to roll out new drugs every 15 years or so to remain in business - whether or not those drugs had any advantages over existing compounds. More recently, companies have focused instead on very expensive “biologics,” drugs that are far harder to make and can largely avoid or delay generic competition. These medicines can be major leaps forward, but they come with serious risks of their own - and frequently do not match their initial hype.

And the crisis in American medicine is not limited to the drug industry. Americans pay far more for healthcare than everyone else in the world, but we are sicker and die younger than people in other rich countries.

At the least, we aren’t getting what we pay for. But more and more I suspect our $4 trillion medical complex is actually hurting us - that the quest for profit is running into the limits of human biology and that much of our innovation is doing more harm than good.

Obviously, I cannot cover every problem in healthcare - or even in just the drug industry - myself. But I can try to shine a light on the biggest crises and worst actors, and I plan to do so.

—

Another issue I will keep writing about is the fertility crisis, which - amazingly - is only deepening. Unreported Truths readers are obviously interested in it, and so am I.

—

As for Berenson v Biden:

We’ve sued; the defendants have filed motions to dismiss; we’ve issued subpoenas to get additional information from Twitter and other third parties; the defendants have tried to block those; we’ve argued they don’t have the right to do so.

All we can do now is wait for Judge Jessica G.L. Clarke to rule.

Interestingly, stories I write about the suit don’t draw huge readerships. My sense is that you are happy enough to let me and James Lawrence fight, but until the suit is further along, you are not necessarily interested in the day-to-day.

I am also somewhat surprised to see you don’t seem particularly interested in having me write about the broader questions of free speech, big tech, and government or quasi-government censorship. (After all, I have a somewhat unique perspective as the only person who has ever sued a social media company and forced my reinstatement.) Maybe that’s because Michael Shellenberger, Matt Taibbi, and other reporters already devote so much energy to the issue.

In any case, I hear you, and intend to stay focused on pharma, where I hope and expect to break news no one else has and provide a unique perspective. (And yes, that does still include Covid and the mRNAs).

—

I thank you all for trusting and supporting me in 2023 - I hope you and your family had a Merry Christmas (or Happy Hanukkah) - and here’s to a great - and truth-filled - 2024!

Onward

Alex